MICROVILLOUS INCLUSION DISEASE

MICROVILLOUS INCLUSION DISEASE was reported 75 times

MICROVILLOUS INCLUSION DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PROBENECID AND COLCHICINE 1 0.0098
1 CHOLESTYRAMINE 13 0.0011
2 CEFUROXIME 12 0.0010
3 TOFACITINIB CITRATE 11 0.0008
4 SIROLIMUS 6 0.0004
5 OLMESARTAN MEDOXOMIL 15 0.0004
6 OCTREOTIDE ACETATE 12 0.0004
7 ALEMTUZUMAB 6 0.0003
8 IPILIMUMAB 12 0.0003
9 MYCOPHENILIC ACID 5 0.0002
10 CIPROFLOXACIN TABLETS 11 0.0002
11 MYCOPHENOLIC ACID 5 0.0002
12 LEVETIRACETAM ORAL 12 0.0002
13 LEVETIRACETAM INJECTION 12 0.0002
14 VEDOLIZUMAB 13 0.0001
15 HYDROCORTISONE 12 0.0001
16 NIVOLUMAB 12 0.0001
17 SOTALOL HYDROCHLORIDE 2 0.0001
18 CIPROFLOXACIN HYDROCHLORIDE 11 0.0001
19 PEMBROLIZUMAB 12 0.0001
20 PREDNISOLONE ORAL SOLUTION 19 0.0001
21 LEVETIRACETAM 12 0.0001
22 METHYLPREDNISOLONE 11 0.0001
23 PANTOPRAZOLE 20 0.0001
24 MYCOPHENOLATE MOFETIL 10 0.0001
25 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 10 0.0001
26 NIFEDIPINE 3 0.0001
27 DABIGATRAN ETEXILATE MESYLATE 5 0.0001
28 DABIGATRAN ETEXILATE 5 0.0001
29 INFLIXIMAB 11 0.0001
30 HUMAN IMMUNOGLOBULIN G 1 0.0000
31 IRBESARTAN 2 0.0000
32 HYDROCHLOROTHIAZIDE 6 0.0000
33 TACROLIMUS OINTMENT 0.1% 5 0.0000
34 TACROLIMUS EXTENDED-RELEASE CAPSULES 5 0.0000
35 TACROLIMUS 6 0.0000
36 PANTOPRAZOLE SODIUM INJECTION 2 0.0000
37 BISOPROLOL FUMARATE 4 0.0000
38 RITUXIMAB 6 0.0000
39 CANDESARTAN 1 0.0000
40 RIVAROXABAN 5 0.0000
41 AZATHIOPRINE 2 0.0000
42 LOPERAMIDE HYDROCHLORIDE 1 0.0000
43 POTASSIUM CHLORIDE ORAL 2 0.0000
44 POTASSIUM CHLORIDE 2 0.0000
45 CONJUGATED ESTROGENS 1 0.0000
46 ESTROGENS, CONJUGATED 1 0.0000
47 LORAZEPAM 3 0.0000
48 OCRELIZUMAB 1 0.0000
49 WARFARIN 2 0.0000
50 CARBAMAZEPINE 1 0.0000
51 SPIRONOLACTONE 2 0.0000
52 PANTOPRAZOLE SODIUM 2 0.0000
53 SIMVASTATIN 3 0.0000
54 FISH OIL 1 0.0000
55 HYDROXYCHLOROQUINE SULFATE 1 0.0000
56 CYCLOSPORINE 1 0.0000
57 PREDNISONE 3 0.0000
58 ATORVASTATIN CALCIUM 1 0.0000
59 AMLODIPINE 1 0.0000
60 GABAPENTIN 1 0.0000